Citation Tools

Extended report
A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease

Download to a citation manager

Cite this article as:
Sibley CH, Chioato A, Felix S, et al
A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease